SHELL WITH CLUSTER HOLES POROUS 52 MM O.D. SIZE II FOR USE WITH II LINERS
Report
- Report Number
- 0001822565-2018-05630
- Event Type
- Injury
- Date Received
- October 10, 2018
- Date of Event
- September 5, 2018
- Report Date
- March 14, 2019
- Manufacturer
- ZIMMER BIOMET, INC.
- Product Code
- LPH
- PMA / PMN Number
- PK091508
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FI
- Reporter Occupation
- PHYSICIAN
Narratives
UPON RECEIPT OF ADDITIONAL INFORMATION, IT HAS BEEN DETERMINED A ZIMMER BIOMET DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE REPORTED EVENT. THE INITIAL REPORT WAS FORWARDED IN ERROR AND SHOULD BE VOIDED.
UPON RECEIPT OF ADDITIONAL INFORMATION, IT HAS BEEN DETERMINED A ZIMMER BIOMET DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE REPORTED EVENT. THE INITIAL REPORT WAS FORWARDED IN ERROR AND SHOULD BE VOIDED.
(B)(4). PATIENT YEAR OF BIRTH (B)(6). CONCOMITANT MEDICAL PRODUCTS: FEMORAL STEM 12/14 NECK TAPER PLASMA SPRAYED PRESS-FIT CEMENTLESS SIZE 7.5 STANDARD OFFSET, PN 00771100700, LN 61694547. METASUL HEAD 36 12/14 SZM/0 /0, PN 00877003602, LN 2564470. METASUL TAPER LINER II/36, PN 00877001036, LN 2555965. REPORTING SOURCE (B)(6). MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT. PLEASE SEE REPORTS: 0001822565-2018-05629. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.
IT WAS REPORTED THAT A PATIENT EXPERIENCED FASCIA LATAE RUPTURE ON THE LEFT HIP. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME. NO FURTHER INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 791994 | SHELL WITH CLUSTER HOLES POROUS 52 MM O.D. SIZE II FOR USE WITH II LINERS | PROSTHESIS HIP | LPH | ZIMMER BIOMET, INC. | N/A | 61726734 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Other |